However, due to the presence of an I148M mutation in PNPLA3, it has been suggested that its association with an increased risk of cardiovascular events is not always consistent, and a definitive causal relationship between NAFLD and CVD cannot be established.45 Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.